首页 | 本学科首页   官方微博 | 高级检索  
检索        

喜炎平联合氨溴索治疗慢性阻塞性肺疾病急性发作期疗效观察
引用本文:麻尔光,李强.喜炎平联合氨溴索治疗慢性阻塞性肺疾病急性发作期疗效观察[J].实用药物与临床,2008,11(4).
作者姓名:麻尔光  李强
作者单位:1. 广西百色民族卫生学校,百色,533000
2. 右江民族医学院附属医院,百色,533000
摘    要:目的探讨喜炎平联合氨溴索治疗慢性阻塞性肺疾病(COPD)急性发作期的效果。方法48例COPD急性发作期患者随机分为治疗组26例,对照组22例。对照组均给予常规治疗,治疗组在常规治疗的基础上,加用喜炎平联合氨溴索治疗,连用1~2周。结果治疗组在治疗后PaO2值升高和PaCO2值降低较对照组显著,治疗组在治疗后FEV1和FEV1占预计值百分比提高较对照组显著,治疗组总有效率高于对照组。结论喜炎平联合氨溴索治疗COPD急性发作期有较好的疗效。

关 键 词:喜炎平  氨溴索  慢性阻塞性肺疾病

Effects of xiyanping combined with ambroxol on acute exacerbation of chronic obstructive pulmonary disease
MA Er-guang,LI Qiang.Effects of xiyanping combined with ambroxol on acute exacerbation of chronic obstructive pulmonary disease[J].Practical Pharmacy and Clinical Remedies,2008,11(4).
Authors:MA Er-guang  LI Qiang
Abstract:Objective To study the effect of xiyanping combined with ambroxol on acute exacerbation of chronic obstructive pulmonary disease(AECOPD).Methods 48 cases of AECOPD were divided into treatment group(26 cases) and control group(22 cases).Regular treatment was given to the two groups,while treatment group was added with xiyanping and ambroxol.Results Significant differences were found in treatment group in the improvement of PaO2,FEV1 and FEV1(%) in pulmonary function and decreased value of PaCO2 after treatment compared with control group.The total effective rate of treatment group were significantly higher than that of control group.Conclusion Xiyanping with ambroxol are effective for the treatment in AECOPD.
Keywords:Xiyanping  Ambroxol  COPD
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号